Showing 1 - 9 results of 9 for search 'Monika Świerczewska', query time: 0.03s
Refine Results
-
1
-
2
-
3
Effect of <i>ALDH1A1</i> Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model by Marta Nowacka, Barbara Ginter-Matuszewska, Monika Świerczewska, Karolina Sterzyńska, Michał Nowicki, Radosław Januchowski
Published 2022-03-01
Article -
4
New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines by Monika Świerczewska, Andrzej Klejewski, Maciej Brązert, Dominika Kaźmierczak, Dariusz Iżycki, Michał Nowicki, Maciej Zabel, Radosław Januchowski
Published 2018-04-01
Article -
5
New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines by Monika Świerczewska, Andrzej Klejewski, Karolina Wojtowicz, Maciej Brązert, Dariusz Iżycki, Michał Nowicki, Maciej Zabel, Radosław Januchowski
Published 2017-10-01
Article -
6
The significance of interferon gamma inducible protein 16 (IFI16) expression in drug resistant ovarian cancer cell lines by Justyna Borucka, Karolina Sterzyńska, Dominika Kaźmierczak, Monika Świerczewska, Marta Nowacka, Karolina Wojtowicz, Andrzej Klejewski, Michał Nowicki, Maciej Zabel, Rodryg Ramlau, Radosław Januchowski
Published 2022-06-01
Article -
7
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays by Joanna Budna-Tukan, Monika Świerczewska, Martine Mazel, Wojciech A. Cieślikowski, Agnieszka Ida, Agnieszka Jankowiak, Andrzej Antczak, Michał Nowicki, Klaus Pantel, David Azria, Maciej Zabel, Catherine Alix-Panabières
Published 2019-06-01
Article -
8
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer by Wojciech A. Cieślikowski, Piotr Milecki, Monika Świerczewska, Agnieszka Ida, Michał Kasperczak, Agnieszka Jankowiak, Michał Nowicki, Klaus Pantel, Catherine Alix-Panabières, Maciej Zabel, Andrzej Antczak, Joanna Budna-Tukan
Published 2023-03-01
Article -
9
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer by Wojciech A. Cieślikowski, Joanna Budna-Tukan, Monika Świerczewska, Agnieszka Ida, Michał Hrab, Agnieszka Jankowiak, Martine Mazel, Michał Nowicki, Piotr Milecki, Klaus Pantel, Catherine Alix-Panabières, Maciej Zabel, Andrzej Antczak
Published 2020-01-01
Article